### Pharmacokinetic Data Semaglutide's pharmacokinetics provide reassurance about occasional missed doses: | Parameter | Value | Clinical Meaning | |---|---|---| | **Half-life** | ~7 days (165 hours) | Drug stays active well beyond the dosing window | | **Time to steady state** | 45 weeks | Multiple doses build to stable levels | | **Bioavailability** | ~89% (subcutaneous) | Highly efficient absorption | | **Volume of distribution** | ~12.5 L | Distributes throughout the body | Because semaglutide accumulates to steady-state over several weeks, a single missed dose causes only a modest dip in circulating levels not a crash
Patients were randomized 3:1:3:1 to semaglutide, matched placebo, liraglutide, matched placebo, and the study enrolled patients at 19 sites in the US
Write down when symptoms occur, how long they last, and whether they happen after a meal, a dose change, or a missed dose
Its important to acknowledge these emotional impacts and take steps to address them
Ho HN, Wu MY, Chen SU, Chao KH, Chen CD, Yang YS: Total antioxidant status and nitric oxide do not increase in peritoneal fluids from women with endometriosis
